Intranasal drug delivery in pediatric emergency departments: brief review and future outlook

키워드

참고문헌 (49)

1. Pansini V, "Intranasal drugs for analgesia and sedation in children admitted to pediatric emergency department : a narrative review", Ann Transl Med, 9, pp.189~ (2021)
2. Poonai N, "Intranasal ketamine for procedural sedation and analgesia in children : a systematic review", PLoS One, 12, pp.e0173253~ (2017)
3. AlSarheed MA, "Intranasal sedatives in pediatric dentistry", Saudi Med J, 37, pp.948~956 (2016)
4. Ryan PM, "Safety and effectiveness of intranasal midazolam and fentanyl used in combination in the pediatric emergency department", Am J Emerg Med, 37, pp.237~240 (2019)
5. Zhang G, "Therapeutic intranasal delivery for stroke and neurological disorders" (2019), Springer
6. Djupesland PG, "The nasal approach to delivering treatment for brain diseases : an anatomic, physiologic, and delivery technology overview", Ther Deliv, 5, pp.709~733 (2014)
7. Xi J, "Growth of nasal and laryngeal airways in children : implications in breathing and inhaled aerosol dynamics", Respir Care, 59, pp.263~273 (2014)
8. Antunes JL, "Nanosystems, Drug Molecule functionalization and intranasal delivery : an update on the most promising strategies for increasing the therapeutic efficacy of antidepressant and anxiolytic drugs", Pharmaceutics, 15, pp.998~ (2023)
9. Crowe TP, "Evaluation of recent intranasal drug delivery systems to the central nervous system", Pharmaceutics, 14, pp.629~ (2022)
10. "Neuroanatomy, cranial nerve 1 (olfactory)" (2022)[URL]
11. Chapman CD, "Intranasal treatment of central nervous system dysfunction in humans", Pharm Res, 30, pp.2475~2484 (2013)
12. Keller LA, "Intranasal drug delivery : opportunities and toxicologic challenges during drug development", Drug Deliv Transl Res, 12, pp.735~757 (2022)
13. Bruinsmann FA, "Nasal drug delivery of anticancer drugs for the treatment of glioblastoma : preclinical and clinical trials", Molecules, 24, pp.4312~ (2019)
14. Wang J, "Intranasal administration of dantrolene increased brain concentration and duration", PLoS One, 15, pp.e0229156~ (2020)
15. Wolfe TR, "Intranasal medication delivery for children : a brief review and update", Pediatrics, 126, pp.532~537 (2010)
16. Rees CA, "Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso-occlusive pain : a multicenter pediatric emergency medicine perspective", Am J Hematol, 98, pp.620~627 (2023)
17. Monzani A, "Not only for caregivers : intranasal glucagon for severe hypoglycaemia in a simulation study", Acta Diabetol, 59, pp.1479~1484 (2022)
18. Settles JA, "Nasal glucagon delivery is more successful than injectable delivery : a simulated severe hypoglycemia rescue", Endocr Pract, 26, pp.407~415 (2020)
19. Choudhary D, "National survey to describe the current patterns of procedural sedation practices among pediatric emergency medicine practitioners in the United States", Pediatr Emerg Care, 38, pp.e321~8 (2022)
20. Oliveira J E Silva L, "Intranasal ketamine for acute pain management in children : a systematic review and meta-analysis", Am J Emerg Med, 38, pp.1860~1866 (2020)
21. Chang JG, "Intranasal fentanyl and midazolam use in children 3 years of age and younger in the emergency department", J Emerg Med, 61, pp.731~739 (2021)
22. Graudins A, "The PICHFORK(Pain in Children Fentanyl or Ketamine)trial : a randomized controlled trial comparing intranasal ketamine and fentanyl for the relief of moderate to severe pain in children with limb injuries", Ann Emerg Med, 65, pp.248~254 (2015)[DOI]
23. Kendall J, "A novel multipatient intranasal diamorphine spray for use in acute pain in children : pharmacovigilance data from an observational study", Emerg Med J, 32, pp.269~273 (2015)
24. Abebe Y, "The effectiveness and safety of paediatric prehospital pain management : a systematic review", Scand J Trauma Resusc Emerg Med, 29, pp.170~ (2021)
25. Bauman BH, "Pediatric pain management in the emergency department", Emerg Med Clin North Am, 23, pp.393~ (2005)[DOI]
26. "FDA alerts health care professionals of potential risks associated with compounded ketamine nasal spray" (2022)[URL]
27. Swisher AR, "Dupilumab adverse events in nasal polyp treatment : analysis of FDA adverse event reporting system", Laryngoscope, 132, pp.2307~2313 (2022)
28. Ahsanuddin S, "Adverse events associated with intranasal sprays : an analysis of the Food and Drug Administration database and literature review", Ann Otol Rhinol Laryngol, 130, pp.1292~1301 (2021)
29. Gondek S, "Assessment and resuscitation in trauma management", Surg Clin North Am, 97, pp.985~998 (2017)
30. Bouida W, "Effect on opioids requirement of early administration of intranasal ketamine for acute traumatic pain", Clin J Pain, 36, pp.458~462 (2020)
31. Erdo´´ F, "Evaluation of intranasal delivery route of drug administration for brain targeting", Brain Res Bull, 143, pp.155~170 (2018)
32. Kendall JM, "Multicentre randomised controlled trial of nasal diamorphine for analgesia in children and teenagers with clinical fractures", BMJ, 322, pp.261~265 (2001)
33. Chafe R, "Improving the treatment and assessment of moderate and severe pain in a pediatric emergency department", Pain Res Manag, 2016, pp.4250109~ (2016)
34. Ruest S, "Management of acute pediatric pain in the emergency department", Curr Opin Pediatr, 28, pp.298~304 (2016)
35. Nemeth M, "Intranasal analgesia and sedation in pediatric emergency care-a prospective observational study on the implementation of an institutional protocol in a tertiary children’s hospital", Pediatr Emerg Care, 35, pp.89~95 (2019)
36. Lane RD, "Atomized intranasal midazolam use for minor procedures in the pediatric emergency department", Pediatr Emerg Care, 24, pp.300~303 (2008)
37. Sado-Filho J, "Randomized clinical trial on the efficacy of intranasal or oral ketamine-midazolam combinations compared to oral midazolam for outpatient pediatric sedation", PLoS One, 14, pp.e0213074~ (2019)
38. Alp H, "Comparison of intranasal midazolam, intranasal ketamine, and oral chloral hydrate for conscious sedation during paediatric echocardiography : results of a prospective randomised study", Cardiol Young, 29, pp.1189~1195 (2019)
39. Li A, "Pharmacokinetic and pharmacodynamic study of intranasal and intravenous dexmedetomidine", Br J Anaesth, 120, pp.960~968 (2018)
40. Borland ML, "Comparative review of the clinical use of intranasal fentanyl versus morphine in a paediatric emergency", Emerg Med Australas, 20, pp.515~520 (2008)
41. Hadley G, "A survey of intranasal medication use in the paediatric emergency setting in England and Wales", Emerg Med J, 27, pp.553~554 (2010)
42. Fowler M, "Knowledge, attitudes and practices of Canadian pediatric emergency physicians regarding short-term opioid use : a descriptive, cross-sectional survey", CMAJ Open, 8, pp.E148~E155 (2020)
43. Waseem M, "Parent and physician preference for anxiolytic medication prior to laceration repair in young children", Cureus, 14, pp.e32412~ (2022)
44. Lorente S, "Effectiveness of procedural sedation and analgesia in pediatric emergencies. A cross-sectional study", J Emerg Nurs, 49, pp.75~85 (2023)
45. Rassy D, "Intranasal methylprednisolone effectively reduces neuroinflammation in mice with experimental autoimmune encephalitis", J Neuropathol Exp Neurol, 79, pp.226~237 (2020)
46. Hayes SH, "Brain targeting and toxicological assessment of the extracellular vesicle-packaged antioxidant catalase-SKL following intranasal administration in mice", Neurotox Res, 39, pp.1418~1429 (2021)
47. Yang Y, "Enhanced nose-to-brain delivery of siRNA using hyaluronan-enveloped nanomicelles for glioma therapy", J Control Release, 342, pp.66~80 (2022)
48. Touitou E, "A new nanovesicular system for nasal drug administration", Int J Pharm, 580, pp.119243~ (2020)
49. Hetrick SE, "New generation antidepressants for depression in children and adolescents : a network meta-analysis", Cochrane Database Syst Rev, 5, pp.CD013674~ (2021)

관련 논문AI추천